Metalloenzyme Inhibitor Patent for Cancer, Alzheimer's, Hemochromatosis
Summary
The European Patent Office published patent application EP4228628A1 for Miralogx LLC covering a metalloenzyme inhibitor compound (3,5-bis(3,4-dihydro-2H-pyrrol-2-yl)-pyridine) for treating cancer, Alzheimer's disease, and hemochromatosis. The patent is classified under organic chemistry (C07D) with pharmaceutical applications (A61K) and therapeutic uses (A61P). The application designates all EU member states plus other EPC contracting states.
What changed
The European Patent Office published patent application EP4228628A1, filed by Miralogx LLC, covering a novel pyridine-based metalloenzyme inhibitor compound for the treatment of cancer, Alzheimer's disease, and hemochromatosis. The application is classified under IPC class C07D (organic chemistry) with therapeutic applications in oncology and neurology.
This patent grant confers exclusive rights to Miralogx LLC across all designated European Patent Convention contracting states for the 20-year patent term from filing. Pharmaceutical companies and researchers developing metalloenzyme inhibitors for these therapeutic indications should conduct freedom-to-operate analyses to assess potential infringement risks in EU markets.
What to do next
- Monitor for updates on patent prosecution progress
- Review freedom-to-operate implications if developing similar inhibitors
- Evaluate licensing opportunities for the designated EU territories
Archived snapshot
Apr 10, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
3,5-BIS(3,4-DIHYDRO-2H-PYRROL-2-YL)-PYRIDINE AS A METALLOENZYME INHIBITOR FOR THE TREATMENT OF CANCER, ALZHEIMER'S DISEASE AND HEMOCHROMATOSIS
Publication EP4228628A1 Kind: A1 Apr 01, 2026
Applicants
Miralogx LLC
Inventors
WILLIAMS, Jonnie, R.
IPC Classifications
C07D 401/04 20060101AFI20240920BHEP A61K 31/4439 20060101ALI20240920BHEP A61P 35/00 20060101ALI20240920BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.